⌘K

Login Start Free

Home/Filings/4/0001209191-15-062079

4//SEC Filing

ANTARES PHARMA, INC. 4

Accession 0001209191-15-062079

CIK 0001016169operating

View on SEC.gov Company Profile

Filed

Jul 21, 8:00 PM ET

Accepted

Jul 22, 6:07 PM ET

Size

5.1 KB

Accession

0001209191-15-062079

Insider Transaction Report

Form 4

Period: 2015-06-22

ANTARES PHARMA, INC.ATRS

Director

Transactions

Tax Payment
Common Stock
2015-06-22$2.41/sh−9,264$22,326→ 435,990 total

Footnotes (1)

[F1]Represents shares withheld to settle tax liability in connection with the vesting of a previously granted restricted stock unit award.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ANTARES PHARMA, INC.

CIK 0001016169

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001016169

Filing Metadata

Form type: 4
Filed: Jul 21, 8:00 PM ET
Accepted: Jul 22, 6:07 PM ET
Size: 5.1 KB

View on SEC.gov